Literature DB >> 24836435

Impact of daily chlorhexidine baths and hand hygiene compliance on nosocomial infection rates in critically ill patients.

Michel Fernando Martínez-Reséndez1, Elvira Garza-González2, Soraya Mendoza-Olazaran2, Alexis Herrera-Guerra3, Juan Manuel Rodríguez-López1, Edelmiro Pérez-Rodriguez4, Roberto Mercado-Longoria5, Adrián Camacho-Ortiz6.   

Abstract

BACKGROUND: Up to 25% of all nosocomial infections (NIs) develop in critically ill patients. Our objective was to evaluate chlorhexidine (CHX) bathing and hand hygiene (HH) compliance in the reduction of NIs in the intensive care unit.
METHODS: The study comprised three 6-month periods: preintervention (PIP; soap/water bathing), intervention (IP; bathing with CHX-impregnated wipes), and postintervention (PoIP; soap/water bathing). An HH program was implemented during the IP and PoIP. Primary outcomes were global and specific NI rates.
RESULTS: A total of 1007 patients were included. Infection rates per 100 discharges were higher in the PIP compared with the IP and also higher in the PoIP compared with the IP (P = .0004 and .0109, respectively). Global infection rates per 1000 hospital-days were higher in the PIP than in the IP (P = .0268). The rates of ventilator-associated pneumonia (VAP) and catheter-associated urinary tract infection (CAUTI) were higher in the PIP than in the IP (P = .036 and .0001, respectively). Isolation of Acinetobacter baumannii from VAP specimens (P = .0204) and isolation of Candida spp from CAUTI specimens (P = .0005) decreased as well.
CONCLUSION: The combined intervention reduced global and specific infection rates, including rates of VAP associated with A baumannii and CAUTI associated with Candida spp.
Copyright © 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Hospital-acquired infection; Infection control; Prevention

Mesh:

Substances:

Year:  2014        PMID: 24836435     DOI: 10.1016/j.ajic.2014.03.354

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

1.  Impact of daily bathing with chlorhexidine gluconate on ventilator associated pneumonia in intensive care units: a meta-analysis.

Authors:  Wensen Chen; Quan Cao; Songqin Li; Huifen Li; Weihong Zhang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

2.  The effect of chlorhexidine on Acinetobacter baumannii in intensive care units.

Authors:  Michel F Martinez-Resendez; Flora Cruz-López; Natalia Gaona-Chávez; Adrián Camacho-Ortiz; Roberto Mercado-Longoria; Samantha Flores-Treviño; Paola Bocanegra-Ibarias; Elvira Garza-González
Journal:  Iran J Microbiol       Date:  2022-02

Review 3.  The efficacy of daily chlorhexidine bathing for preventing healthcare-associated infections in adult intensive care units.

Authors:  Hua-Ping Huang; Bin Chen; Hai-Yan Wang; Me He
Journal:  Korean J Intern Med       Date:  2016-04-06       Impact factor: 2.884

4.  A simplified prevention bundle with dual hand hygiene audit reduces early-onset ventilator-associated pneumonia in cardiovascular surgery units: An interrupted time-series analysis.

Authors:  Kang-Cheng Su; Yu Ru Kou; Fang-Chi Lin; Chieh-Hung Wu; Jia-Yih Feng; Shiang-Fen Huang; Tao-Fen Shiung; Kwei-Chun Chung; Yu-Hsiu Tung; Kuang-Yao Yang; Shi-Chuan Chang
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

Review 5.  The Effects of Chlorhexidine Dressing on Health Care-Associated Infection in Hospitalized Patients: A Meta-Analysis.

Authors:  Hou-Xing Wang; Shu-Yuan Xie; Hao Wang; Hao-Kai Chu
Journal:  Iran J Public Health       Date:  2019-05       Impact factor: 1.429

6.  Improving hand hygiene compliance among healthcare workers: an intervention study in a Hospital in Guizhou Province, China.

Authors:  Xia Mu; Yan Xu; Tingxiu Yang; Ji Zhang; Chong Wang; Wei Liu; Jing Chen; Luyu Tang; Huai Yang
Journal:  Braz J Infect Dis       Date:  2016-06-25       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.